Contract 75N91019F00130
Fred Hutchinson Cancer Center · Department Of Health And Human Services · September 14, 2021
Fred Hutchinson Cancer Center was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 14, 2021 for $2.48 million (current value) of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Seattle, WA. This is a task or delivery order issued under parent IDIQ 75N91018D00004. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 15, 2024. If all options are exercised, the contract could reach $2.48 million.
Contract details
- PIID
- 75N91019F00130
- Parent IDIQ
- 75N91018D00004
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Seattle, WA
- First action
- September 14, 2021
- Latest action
- August 15, 2024
Description
SEER*EDUCATE
Modification timeline
-
August 15, 2024Mod P00005 · Supplemental Agreement For Work Within Scope$2.48M
-
June 24, 2024Mod P00001 · Funding Only ActionTOFRP A - SINGLE CELL SEQUENCING TASK ORDER FOR NCI'S GENOMIC CHARACTERIZATION CENTER PERIOD OF PERFORMANCE 09/16/2019 - 09/15/2022$190.7K
-
September 29, 2022Mod P00011 · Supplemental Agreement For Work Within ScopeR&D SERVICES RELATED TO CGMP MANUFACTURING (VACCINE)$3.87M
-
September 14, 2021Mod P00002 · Exercise An OptionFOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL$869.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $327.13M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| Lovelace Biomedical Research Institute | Department Of Health And Human Services | April 1, 2026 | $680.2K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| The Brain Donor Project, Inc | Department Of Health And Human Services | April 1, 2026 | $1.27M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91019F00130?
Contract 75N91019F00130 is a federal contract awarded to Fred Hutchinson Cancer Center by Department Of Health And Human Services on September 14, 2021 for $2.48 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75N91019F00130?
Fred Hutchinson Cancer Center won contract 75N91019F00130 from Department Of Health And Human Services.
How much is contract 75N91019F00130 worth?
Contract 75N91019F00130 has obligated $0 to date but carries a potential ceiling of $2.48 million if fully funded and all options are exercised.